2011
DOI: 10.1590/s0365-05962011000100006
|View full text |Cite
|
Sign up to set email alerts
|

Eficácia da combinação tópica de peróxido de benzoíla 5% e clindamicina 1% para o tratamento da hipomelanose macular progressiva: um estudo randomizado, duplo-cego, placebo-controlado

Abstract: The topical combination of benzoyl peroxide 5% and clindamycin 1% is effective in the treatment of progressive macular hypomelanosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
1

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(2 citation statements)
references
References 6 publications
0
1
0
1
Order By: Relevance
“…1a) ; on average, 73.9% of the reads belonged to this type. In contrast, in the matching control samples, only 14.2% of the reads could be assigned to P. acnes type III ( p value 7.8 × 10- 5 ). Instead, control samples contained a higher proportion of type IA1 (STs “A” to “E”) strains (56.8%) and type II (ST “K”) strains (22.3%), while these were found in much lower proportions in PMH lesions: type IA1 (12.8%) and type II (5.6%).…”
Section: Resultsmentioning
confidence: 87%
“…1a) ; on average, 73.9% of the reads belonged to this type. In contrast, in the matching control samples, only 14.2% of the reads could be assigned to P. acnes type III ( p value 7.8 × 10- 5 ). Instead, control samples contained a higher proportion of type IA1 (STs “A” to “E”) strains (56.8%) and type II (ST “K”) strains (22.3%), while these were found in much lower proportions in PMH lesions: type IA1 (12.8%) and type II (5.6%).…”
Section: Resultsmentioning
confidence: 87%
“…Referente ao perfil de resistência, foram avaliados os antimicrobianos classes A e B para os quatro microrganismos prevalentes 12 . Relacionado ao S. aureus, 36,44% apresentaram resistência à clindamicina, tal medicamento é usado frente anaeróbicos e com frequência em pomadas para uso tópico 13 . A clindamicina é um importante agente terapêutico para as infecções por MRSA, principalmente em infecções de tecidos moles.…”
Section: Antimicrobianosunclassified